{"transactions":[{"id":2205430,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-07-19T16:40:13.000Z","date":"2022-07-15","kind":"exercise","acquired":false,"shares":46034,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Immediately exercisable."}],"balance_after":8755,"derivative":{"exercise_price":0.3,"expiration_date":"2028-03-25","underlying":"Common Stock","underlying_shares":46034},"source":{"system":"sec-edgar","filing":"0001209191-22-042573","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919122042573/doc4.xml","form_type":"4"}},{"id":2205429,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-07-19T16:40:13.000Z","date":"2022-07-15","kind":"sale","acquired":false,"shares":46034,"price":30,"value":1381020.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":95100,"source":{"system":"sec-edgar","filing":"0001209191-22-042573","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919122042573/doc4.xml","form_type":"4"}},{"id":2205428,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-07-19T16:40:13.000Z","date":"2022-07-15","kind":"exercise","acquired":true,"shares":46034,"price":0.3,"value":13810.2,"ownership":{"direct":true},"balance_after":141134,"source":{"system":"sec-edgar","filing":"0001209191-22-042573","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919122042573/doc4.xml","form_type":"4"}},{"id":2207081,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-07-15T16:40:45.000Z","date":"2022-07-13","kind":"exercise","acquired":false,"shares":1916,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Immediately exercisable."}],"balance_after":54789,"derivative":{"exercise_price":0.3,"expiration_date":"2028-03-25","underlying":"Common Stock","underlying_shares":1916},"source":{"system":"sec-edgar","filing":"0001209191-22-042253","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919122042253/doc4.xml","form_type":"4"}},{"id":2207080,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-07-15T16:40:45.000Z","date":"2022-07-13","kind":"sale","acquired":false,"shares":1916,"price":30,"value":57480.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":95100,"source":{"system":"sec-edgar","filing":"0001209191-22-042253","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919122042253/doc4.xml","form_type":"4"}},{"id":2207079,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-07-15T16:40:45.000Z","date":"2022-07-13","kind":"exercise","acquired":true,"shares":1916,"price":0.3,"value":574.8,"ownership":{"direct":true},"balance_after":93184,"source":{"system":"sec-edgar","filing":"0001209191-22-042253","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919122042253/doc4.xml","form_type":"4"}},{"id":2232789,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-06-14T18:57:12.000Z","date":"2022-06-14","kind":"exercise","acquired":false,"shares":9400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Immediately exercisable."}],"balance_after":56705,"derivative":{"exercise_price":0.3,"expiration_date":"2028-03-25","underlying":"Common Stock","underlying_shares":9400},"source":{"system":"sec-edgar","filing":"0001209191-22-036800","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919122036800/doc4.xml","form_type":"4"}},{"id":2232788,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-06-14T18:57:12.000Z","date":"2022-06-14","kind":"exercise","acquired":true,"shares":9400,"price":0.3,"value":2820.0,"ownership":{"direct":true},"balance_after":95100,"source":{"system":"sec-edgar","filing":"0001209191-22-036800","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919122036800/doc4.xml","form_type":"4"}},{"id":2272181,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-05-13T16:37:35.000Z","date":"2022-05-11","kind":"exercise","acquired":false,"shares":5300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Immediately exercisable."}],"balance_after":66105,"derivative":{"exercise_price":0.3,"expiration_date":"2028-03-25","underlying":"Common Stock","underlying_shares":5300},"source":{"system":"sec-edgar","filing":"0001209191-22-028889","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919122028889/doc4.xml","form_type":"4"}},{"id":2272180,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-05-13T16:37:35.000Z","date":"2022-05-11","kind":"sale","acquired":false,"shares":16,"price":45.45,"value":727.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.31 to $45.46 inclusive."}],"balance_after":85700,"source":{"system":"sec-edgar","filing":"0001209191-22-028889","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919122028889/doc4.xml","form_type":"4"}},{"id":2272179,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-05-13T16:37:35.000Z","date":"2022-05-11","kind":"sale","acquired":false,"shares":223,"price":44.23,"value":9863.29,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.075 to $44.43 inclusive."}],"balance_after":85716,"source":{"system":"sec-edgar","filing":"0001209191-22-028889","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919122028889/doc4.xml","form_type":"4"}},{"id":2272178,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-05-13T16:37:35.000Z","date":"2022-05-11","kind":"sale","acquired":false,"shares":719,"price":43.32,"value":31147.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.04 to $43.62 inclusive."}],"balance_after":85939,"source":{"system":"sec-edgar","filing":"0001209191-22-028889","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919122028889/doc4.xml","form_type":"4"}},{"id":2272177,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-05-13T16:37:35.000Z","date":"2022-05-11","kind":"sale","acquired":false,"shares":944,"price":42.49,"value":40110.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.915 to $42.90 inclusive."}],"balance_after":86658,"source":{"system":"sec-edgar","filing":"0001209191-22-028889","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919122028889/doc4.xml","form_type":"4"}},{"id":2272176,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-05-13T16:37:35.000Z","date":"2022-05-11","kind":"sale","acquired":false,"shares":3398,"price":41.26,"value":140201.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.915 to $41.88 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5) and (6)."}],"balance_after":87602,"source":{"system":"sec-edgar","filing":"0001209191-22-028889","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919122028889/doc4.xml","form_type":"4"}},{"id":2272175,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-05-13T16:37:35.000Z","date":"2022-05-11","kind":"exercise","acquired":true,"shares":5300,"price":0.3,"value":1590.0,"ownership":{"direct":true},"balance_after":91000,"source":{"system":"sec-edgar","filing":"0001209191-22-028889","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919122028889/doc4.xml","form_type":"4"}},{"id":2297811,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-04-13T16:36:15.000Z","date":"2022-04-11","kind":"exercise","acquired":false,"shares":5300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Immediately exercisable."}],"balance_after":71405,"derivative":{"exercise_price":0.3,"expiration_date":"2028-03-25","underlying":"Common Stock","underlying_shares":5300},"source":{"system":"sec-edgar","filing":"0001209191-22-024290","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919122024290/doc4.xml","form_type":"4"}},{"id":2297810,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-04-13T16:36:15.000Z","date":"2022-04-11","kind":"sale","acquired":false,"shares":559,"price":64.15,"value":35859.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.00 to $64.49 inclusive."}],"balance_after":85700,"source":{"system":"sec-edgar","filing":"0001209191-22-024290","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919122024290/doc4.xml","form_type":"4"}},{"id":2297809,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-04-13T16:36:15.000Z","date":"2022-04-11","kind":"sale","acquired":false,"shares":2315,"price":63.5,"value":147002.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.975 to $63.865 inclusive."}],"balance_after":86259,"source":{"system":"sec-edgar","filing":"0001209191-22-024290","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919122024290/doc4.xml","form_type":"4"}},{"id":2297808,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-04-13T16:36:15.000Z","date":"2022-04-11","kind":"sale","acquired":false,"shares":1009,"price":62.32,"value":62880.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.975 to $62.97 inclusive."}],"balance_after":88574,"source":{"system":"sec-edgar","filing":"0001209191-22-024290","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919122024290/doc4.xml","form_type":"4"}},{"id":2297807,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-04-13T16:36:15.000Z","date":"2022-04-11","kind":"sale","acquired":false,"shares":1417,"price":61.37,"value":86961.29,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.97 to $61.935 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4) and (5)."}],"balance_after":89583,"source":{"system":"sec-edgar","filing":"0001209191-22-024290","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919122024290/doc4.xml","form_type":"4"}},{"id":2297806,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-04-13T16:36:15.000Z","date":"2022-04-11","kind":"exercise","acquired":true,"shares":5300,"price":0.3,"value":1590.0,"ownership":{"direct":true},"balance_after":91000,"source":{"system":"sec-edgar","filing":"0001209191-22-024290","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919122024290/doc4.xml","form_type":"4"}},{"id":2302655,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"of Shares Employee Stock Option (right to buy)","published_at":"2022-04-06T16:49:31.000Z","date":"2022-04-04","kind":"exercise","acquired":false,"shares":7950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Immediately exercisable."}],"balance_after":76705,"derivative":{"exercise_price":0.3,"expiration_date":"2028-03-25","underlying":"Common Stock","underlying_shares":7950},"source":{"system":"sec-edgar","filing":"0001209191-22-023494","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919122023494/doc4.xml","form_type":"4"}},{"id":2302654,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-04-06T16:49:31.000Z","date":"2022-04-04","kind":"sale","acquired":false,"shares":7950,"price":60,"value":477000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":85700,"source":{"system":"sec-edgar","filing":"0001209191-22-023494","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919122023494/doc4.xml","form_type":"4"}},{"id":2302653,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-04-06T16:49:31.000Z","date":"2022-04-04","kind":"exercise","acquired":true,"shares":7950,"price":0.3,"value":2385.0,"ownership":{"direct":true},"balance_after":93650,"source":{"system":"sec-edgar","filing":"0001209191-22-023494","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919122023494/doc4.xml","form_type":"4"}},{"id":2333498,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-03-15T16:37:04.000Z","date":"2022-03-11","kind":"exercise","acquired":false,"shares":2650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Immediately exercisable."}],"balance_after":84655,"derivative":{"exercise_price":0.3,"expiration_date":"2028-03-25","underlying":"Common Stock","underlying_shares":2650},"source":{"system":"sec-edgar","filing":"0001209191-22-018836","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919122018836/doc4.xml","form_type":"4"}},{"id":2333497,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-03-15T16:37:04.000Z","date":"2022-03-11","kind":"sale","acquired":false,"shares":875,"price":54.54,"value":47722.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.225 to $55.13 inclusive."}],"balance_after":85700,"source":{"system":"sec-edgar","filing":"0001209191-22-018836","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919122018836/doc4.xml","form_type":"4"}},{"id":2333496,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-03-15T16:37:04.000Z","date":"2022-03-11","kind":"sale","acquired":false,"shares":713,"price":53.36,"value":38045.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.06 to $53.83 inclusive."}],"balance_after":86575,"source":{"system":"sec-edgar","filing":"0001209191-22-018836","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919122018836/doc4.xml","form_type":"4"}},{"id":2333495,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-03-15T16:37:04.000Z","date":"2022-03-11","kind":"sale","acquired":false,"shares":1062,"price":52.43,"value":55680.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.03 to $53.025 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4)."}],"balance_after":87288,"source":{"system":"sec-edgar","filing":"0001209191-22-018836","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919122018836/doc4.xml","form_type":"4"}},{"id":2333494,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-03-15T16:37:04.000Z","date":"2022-03-11","kind":"exercise","acquired":true,"shares":2650,"price":0.3,"value":795.0,"ownership":{"direct":true},"balance_after":88350,"source":{"system":"sec-edgar","filing":"0001209191-22-018836","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919122018836/doc4.xml","form_type":"4"}},{"id":2394690,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-02-15T16:26:10.000Z","date":"2022-02-11","kind":"exercise","acquired":false,"shares":2650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Immediately exercisable."}],"balance_after":87305,"derivative":{"exercise_price":0.3,"expiration_date":"2028-03-25","underlying":"Common Stock","underlying_shares":2650},"source":{"system":"sec-edgar","filing":"0001209191-22-009792","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919122009792/doc4.xml","form_type":"4"}},{"id":2394689,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-02-15T16:26:10.000Z","date":"2022-02-11","kind":"sale","acquired":false,"shares":199,"price":53.1,"value":10566.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.06 to $53.17 inclusive."}],"balance_after":85700,"source":{"system":"sec-edgar","filing":"0001209191-22-009792","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919122009792/doc4.xml","form_type":"4"}},{"id":2394688,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-02-15T16:26:10.000Z","date":"2022-02-11","kind":"sale","acquired":false,"shares":1378,"price":52.35,"value":72138.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.99 to $52.805 inclusive."}],"balance_after":85899,"source":{"system":"sec-edgar","filing":"0001209191-22-009792","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919122009792/doc4.xml","form_type":"4"}},{"id":2394687,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-02-15T16:26:10.000Z","date":"2022-02-11","kind":"sale","acquired":false,"shares":1073,"price":51.5,"value":55259.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.97 to $51.63 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4)."}],"balance_after":87277,"source":{"system":"sec-edgar","filing":"0001209191-22-009792","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919122009792/doc4.xml","form_type":"4"}},{"id":2394686,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-02-15T16:26:10.000Z","date":"2022-02-11","kind":"exercise","acquired":true,"shares":2650,"price":0.3,"value":795.0,"ownership":{"direct":true},"balance_after":88350,"source":{"system":"sec-edgar","filing":"0001209191-22-009792","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919122009792/doc4.xml","form_type":"4"}},{"id":2426820,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-01-25T16:14:05.000Z","date":"2022-01-21","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth (1/4th) of the shares subject to the option shall vest on January 19, 2023, and one-twelfth (1/12th) of the remaining shares subject to the option shall vest in equal quarterly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":50000,"derivative":{"exercise_price":46.3,"expiration_date":"2032-01-20","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-22-004763","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919122004763/doc4.xml","form_type":"4"}},{"id":2436056,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-01-13T16:39:37.000Z","date":"2022-01-11","kind":"exercise","acquired":false,"shares":2650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Immediately exercisable."}],"balance_after":89955,"derivative":{"exercise_price":0.3,"expiration_date":"2028-03-25","underlying":"Common Stock","underlying_shares":2650},"source":{"system":"sec-edgar","filing":"0001209191-22-003198","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919122003198/doc4.xml","form_type":"4"}},{"id":2436055,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-01-13T16:39:37.000Z","date":"2022-01-11","kind":"sale","acquired":false,"shares":1134,"price":54.45,"value":61746.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.075 to $54.85 inclusive."}],"balance_after":85700,"source":{"system":"sec-edgar","filing":"0001209191-22-003198","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919122003198/doc4.xml","form_type":"4"}},{"id":2436054,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-01-13T16:39:37.000Z","date":"2022-01-11","kind":"sale","acquired":false,"shares":1196,"price":53.56,"value":64057.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.035 to $53.98 inclusive."}],"balance_after":86834,"source":{"system":"sec-edgar","filing":"0001209191-22-003198","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919122003198/doc4.xml","form_type":"4"}},{"id":2436053,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-01-13T16:39:37.000Z","date":"2022-01-11","kind":"sale","acquired":false,"shares":320,"price":52.01,"value":16643.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.695 to $52.45 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4)."}],"balance_after":88030,"source":{"system":"sec-edgar","filing":"0001209191-22-003198","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919122003198/doc4.xml","form_type":"4"}},{"id":2436052,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-01-13T16:39:37.000Z","date":"2022-01-11","kind":"exercise","acquired":true,"shares":2650,"price":0.3,"value":795.0,"ownership":{"direct":true},"balance_after":88350,"source":{"system":"sec-edgar","filing":"0001209191-22-003198","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919122003198/doc4.xml","form_type":"4"}},{"id":2440232,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-01-07T16:35:43.000Z","date":"2022-01-05","kind":"exercise","acquired":false,"shares":2650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Immediately exercisable."}],"balance_after":92605,"derivative":{"exercise_price":0.3,"expiration_date":"2028-03-25","underlying":"Common Stock","underlying_shares":2650},"source":{"system":"sec-edgar","filing":"0001209191-22-002416","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919122002416/doc4.xml","form_type":"4"}},{"id":2440231,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-01-07T16:35:43.000Z","date":"2022-01-05","kind":"sale","acquired":false,"shares":2650,"price":60,"value":159000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":85700,"source":{"system":"sec-edgar","filing":"0001209191-22-002416","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919122002416/doc4.xml","form_type":"4"}},{"id":2440230,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-01-07T16:35:43.000Z","date":"2022-01-05","kind":"exercise","acquired":true,"shares":2650,"price":0.3,"value":795.0,"ownership":{"direct":true},"balance_after":88350,"source":{"system":"sec-edgar","filing":"0001209191-22-002416","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919122002416/doc4.xml","form_type":"4"}},{"id":2471733,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-12-15T16:48:41.000Z","date":"2021-12-15","kind":"exercise","acquired":false,"shares":735,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Immediately exercisable."}],"balance_after":95255,"derivative":{"exercise_price":0.3,"expiration_date":"2028-03-25","underlying":"Common Stock","underlying_shares":735},"source":{"system":"sec-edgar","filing":"0001209191-21-069767","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919121069767/doc4.xml","form_type":"4"}},{"id":2471732,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-12-15T16:48:41.000Z","date":"2021-12-13","kind":"exercise","acquired":false,"shares":1915,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Immediately exercisable."}],"balance_after":95990,"derivative":{"exercise_price":0.3,"expiration_date":"2028-03-25","underlying":"Common Stock","underlying_shares":1915},"source":{"system":"sec-edgar","filing":"0001209191-21-069767","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919121069767/doc4.xml","form_type":"4"}},{"id":2471731,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-12-15T16:48:41.000Z","date":"2021-12-15","kind":"sale","acquired":false,"shares":735,"price":50,"value":36750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":85700,"source":{"system":"sec-edgar","filing":"0001209191-21-069767","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919121069767/doc4.xml","form_type":"4"}},{"id":2471730,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-12-15T16:48:41.000Z","date":"2021-12-15","kind":"exercise","acquired":true,"shares":735,"price":0.3,"value":220.5,"ownership":{"direct":true},"balance_after":86435,"source":{"system":"sec-edgar","filing":"0001209191-21-069767","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919121069767/doc4.xml","form_type":"4"}},{"id":2471729,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-12-15T16:48:41.000Z","date":"2021-12-13","kind":"sale","acquired":false,"shares":7,"price":53.64,"value":375.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":85700,"source":{"system":"sec-edgar","filing":"0001209191-21-069767","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919121069767/doc4.xml","form_type":"4"}},{"id":2471728,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-12-15T16:48:41.000Z","date":"2021-12-13","kind":"sale","acquired":false,"shares":390,"price":52.22,"value":20365.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.06 to $52.86 inclusive."}],"balance_after":85707,"source":{"system":"sec-edgar","filing":"0001209191-21-069767","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919121069767/doc4.xml","form_type":"4"}},{"id":2471727,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-12-15T16:48:41.000Z","date":"2021-12-13","kind":"sale","acquired":false,"shares":1518,"price":50.11,"value":76066.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.495 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3)."}],"balance_after":86097,"source":{"system":"sec-edgar","filing":"0001209191-21-069767","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919121069767/doc4.xml","form_type":"4"}},{"id":2471726,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-12-15T16:48:41.000Z","date":"2021-12-13","kind":"exercise","acquired":true,"shares":1915,"price":0.3,"value":574.5,"ownership":{"direct":true},"balance_after":87615,"source":{"system":"sec-edgar","filing":"0001209191-21-069767","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919121069767/doc4.xml","form_type":"4"}},{"id":2515318,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-11-12T16:40:00.000Z","date":"2021-11-11","kind":"exercise","acquired":false,"shares":5300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Immediately exercisable."}],"balance_after":97905,"derivative":{"exercise_price":0.3,"expiration_date":"2028-03-25","underlying":"Common Stock","underlying_shares":5300},"source":{"system":"sec-edgar","filing":"0001209191-21-064218","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919121064218/doc4.xml","form_type":"4"}},{"id":2515317,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-11-12T16:40:00.000Z","date":"2021-11-10","kind":"exercise","acquired":false,"shares":15900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Immediately exercisable."}],"balance_after":103205,"derivative":{"exercise_price":0.3,"expiration_date":"2028-03-25","underlying":"Common Stock","underlying_shares":15900},"source":{"system":"sec-edgar","filing":"0001209191-21-064218","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919121064218/doc4.xml","form_type":"4"}},{"id":2515316,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-11-12T16:40:00.000Z","date":"2021-11-11","kind":"sale","acquired":false,"shares":4561,"price":59.78,"value":272656.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.145 to $60.07 inclusive."}],"balance_after":85700,"source":{"system":"sec-edgar","filing":"0001209191-21-064218","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919121064218/doc4.xml","form_type":"4"}},{"id":2515315,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-11-12T16:40:00.000Z","date":"2021-11-11","kind":"sale","acquired":false,"shares":739,"price":58.73,"value":43401.47,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.125 to $59.03 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3)."}],"balance_after":90261,"source":{"system":"sec-edgar","filing":"0001209191-21-064218","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919121064218/doc4.xml","form_type":"4"}},{"id":2515314,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-11-12T16:40:00.000Z","date":"2021-11-11","kind":"exercise","acquired":true,"shares":5300,"price":0.3,"value":1590.0,"ownership":{"direct":true},"balance_after":91000,"source":{"system":"sec-edgar","filing":"0001209191-21-064218","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919121064218/doc4.xml","form_type":"4"}},{"id":2515313,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-11-12T16:40:00.000Z","date":"2021-11-10","kind":"sale","acquired":false,"shares":15900,"price":60,"value":954000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":85700,"source":{"system":"sec-edgar","filing":"0001209191-21-064218","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919121064218/doc4.xml","form_type":"4"}},{"id":2515312,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-11-12T16:40:00.000Z","date":"2021-11-10","kind":"exercise","acquired":true,"shares":15900,"price":0.3,"value":4770.0,"ownership":{"direct":true},"balance_after":101600,"source":{"system":"sec-edgar","filing":"0001209191-21-064218","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919121064218/doc4.xml","form_type":"4"}},{"id":2523110,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-11-05T17:06:39.000Z","date":"2021-11-04","kind":"exercise","acquired":false,"shares":10600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Immediately exercisable."}],"balance_after":119105,"derivative":{"exercise_price":0.3,"expiration_date":"2028-03-25","underlying":"Common Stock","underlying_shares":10600},"source":{"system":"sec-edgar","filing":"0001209191-21-063210","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919121063210/doc4.xml","form_type":"4"}},{"id":2523109,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-11-05T17:06:39.000Z","date":"2021-11-04","kind":"sale","acquired":false,"shares":10600,"price":50,"value":530000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":85700,"source":{"system":"sec-edgar","filing":"0001209191-21-063210","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919121063210/doc4.xml","form_type":"4"}},{"id":2523108,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-11-05T17:06:39.000Z","date":"2021-11-04","kind":"exercise","acquired":true,"shares":10600,"price":0.3,"value":3180.0,"ownership":{"direct":true},"balance_after":96300,"source":{"system":"sec-edgar","filing":"0001209191-21-063210","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919121063210/doc4.xml","form_type":"4"}},{"id":2598101,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-08-18T17:21:47.000Z","date":"2021-08-17","kind":"exercise","acquired":false,"shares":1293,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Immediately exercisable."}],"balance_after":0,"derivative":{"exercise_price":0.3,"expiration_date":"2028-03-25","underlying":"Common Stock","underlying_shares":1293},"source":{"system":"sec-edgar","filing":"0001209191-21-052271","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919121052271/doc4.xml","form_type":"4"}},{"id":2598100,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-08-18T17:21:47.000Z","date":"2021-08-17","kind":"exercise","acquired":true,"shares":1293,"price":0.3,"value":387.9,"ownership":{"direct":true},"balance_after":85700,"source":{"system":"sec-edgar","filing":"0001209191-21-052271","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919121052271/doc4.xml","form_type":"4"}},{"id":2654953,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-06-25T18:29:35.000Z","date":"2021-06-24","kind":"exercise","acquired":false,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Immediately exercisable."}],"balance_after":1293,"derivative":{"exercise_price":0.3,"expiration_date":"2028-03-25","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001209191-21-043392","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919121043392/doc4.xml","form_type":"4"}},{"id":2654952,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-06-25T18:29:35.000Z","date":"2021-06-24","kind":"exercise","acquired":true,"shares":6500,"price":0.3,"value":1950.0,"ownership":{"direct":true},"balance_after":84407,"source":{"system":"sec-edgar","filing":"0001209191-21-043392","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919121043392/doc4.xml","form_type":"4"}},{"id":2668634,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-06-15T17:02:40.000Z","date":"2021-06-11","kind":"exercise","acquired":false,"shares":2650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Immediately exercisable."}],"balance_after":129705,"derivative":{"exercise_price":0.3,"expiration_date":"2028-03-25","underlying":"Common Stock","underlying_shares":2650},"source":{"system":"sec-edgar","filing":"0001209191-21-040651","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919121040651/doc4.xml","form_type":"4"}},{"id":2668633,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-06-15T17:02:40.000Z","date":"2021-06-11","kind":"sale","acquired":false,"shares":219,"price":52.13,"value":11416.47,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.12 to $52.53 inclusive."}],"balance_after":77907,"source":{"system":"sec-edgar","filing":"0001209191-21-040651","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919121040651/doc4.xml","form_type":"4"}},{"id":2668632,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-06-15T17:02:40.000Z","date":"2021-06-11","kind":"sale","acquired":false,"shares":898,"price":51.73,"value":46453.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.065 to $52.05 inclusive."}],"balance_after":78126,"source":{"system":"sec-edgar","filing":"0001209191-21-040651","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919121040651/doc4.xml","form_type":"4"}},{"id":2668631,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-06-15T17:02:40.000Z","date":"2021-06-11","kind":"sale","acquired":false,"shares":1533,"price":50.37,"value":77217.21,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to\n$50.96 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and\nExchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in\nfootnotes (2), (3) and (4)."}],"balance_after":79024,"source":{"system":"sec-edgar","filing":"0001209191-21-040651","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919121040651/doc4.xml","form_type":"4"}},{"id":2668630,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-06-15T17:02:40.000Z","date":"2021-06-11","kind":"exercise","acquired":true,"shares":2650,"price":0.3,"value":795.0,"ownership":{"direct":true},"balance_after":80557,"source":{"system":"sec-edgar","filing":"0001209191-21-040651","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919121040651/doc4.xml","form_type":"4"}},{"id":2714660,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-05-13T16:36:12.000Z","date":"2021-05-13","kind":"exercise","acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-twelfth (1/12th) of the shares subject to the option vested or shall vest in equal quarterly installments commencing on March 18, 2018, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":7793,"derivative":{"exercise_price":0.3,"expiration_date":"2028-03-25","underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001209191-21-032358","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919121032358/doc4.xml","form_type":"4"}},{"id":2714659,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-05-13T16:36:12.000Z","date":"2021-05-13","kind":"exercise","acquired":false,"shares":6220,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Immediately exercisable."}],"balance_after":0,"derivative":{"exercise_price":0.11,"expiration_date":"2027-04-02","underlying":"Common Stock","underlying_shares":6220},"source":{"system":"sec-edgar","filing":"0001209191-21-032358","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919121032358/doc4.xml","form_type":"4"}},{"id":2714658,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-05-13T16:36:12.000Z","date":"2021-05-11","kind":"exercise","acquired":false,"shares":2650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Immediately exercisable."}],"balance_after":132355,"derivative":{"exercise_price":0.3,"expiration_date":"2028-03-25","underlying":"Common Stock","underlying_shares":2650},"source":{"system":"sec-edgar","filing":"0001209191-21-032358","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919121032358/doc4.xml","form_type":"4"}},{"id":2714657,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-05-13T16:36:12.000Z","date":"2021-05-13","kind":"exercise","acquired":true,"shares":500,"price":0.3,"value":150.0,"ownership":{"direct":true},"balance_after":77907,"source":{"system":"sec-edgar","filing":"0001209191-21-032358","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919121032358/doc4.xml","form_type":"4"}},{"id":2714656,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-05-13T16:36:12.000Z","date":"2021-05-13","kind":"exercise","acquired":true,"shares":6220,"price":0.11,"value":684.2,"ownership":{"direct":true},"balance_after":77407,"source":{"system":"sec-edgar","filing":"0001209191-21-032358","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919121032358/doc4.xml","form_type":"4"}},{"id":2714655,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-05-13T16:36:12.000Z","date":"2021-05-11","kind":"sale","acquired":false,"shares":2650,"price":50,"value":132500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":71187,"source":{"system":"sec-edgar","filing":"0001209191-21-032358","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919121032358/doc4.xml","form_type":"4"}},{"id":2714654,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-05-13T16:36:12.000Z","date":"2021-05-11","kind":"exercise","acquired":true,"shares":2650,"price":0.3,"value":795.0,"ownership":{"direct":true},"balance_after":73837,"source":{"system":"sec-edgar","filing":"0001209191-21-032358","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919121032358/doc4.xml","form_type":"4"}},{"id":2749654,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-04-14T16:43:36.000Z","date":"2021-04-12","kind":"exercise","acquired":false,"shares":5300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Immediately exercisable."}],"balance_after":135005,"derivative":{"exercise_price":0.3,"expiration_date":"2028-03-25","underlying":"Common Stock","underlying_shares":5300},"source":{"system":"sec-edgar","filing":"0001209191-21-026666","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919121026666/doc4.xml","form_type":"4"}},{"id":2749653,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-04-14T16:43:36.000Z","date":"2021-04-12","kind":"sale","acquired":false,"shares":100,"price":61.72,"value":6172.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.625 to $61.725 inclusive"}],"balance_after":71187,"source":{"system":"sec-edgar","filing":"0001209191-21-026666","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919121026666/doc4.xml","form_type":"4"}},{"id":2749652,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-04-14T16:43:36.000Z","date":"2021-04-12","kind":"sale","acquired":false,"shares":729,"price":61.08,"value":44527.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.58 to $61.535 inclusive."}],"balance_after":71287,"source":{"system":"sec-edgar","filing":"0001209191-21-026666","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919121026666/doc4.xml","form_type":"4"}},{"id":2749651,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-04-14T16:43:36.000Z","date":"2021-04-12","kind":"sale","acquired":false,"shares":3473,"price":59.99,"value":208345.27,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.55 to $60.43 inclusive."}],"balance_after":72016,"source":{"system":"sec-edgar","filing":"0001209191-21-026666","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919121026666/doc4.xml","form_type":"4"}},{"id":2749650,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-04-14T16:43:36.000Z","date":"2021-04-12","kind":"sale","acquired":false,"shares":998,"price":59.1,"value":58981.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.54 to $59.52 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4) and (5)."}],"balance_after":75489,"source":{"system":"sec-edgar","filing":"0001209191-21-026666","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919121026666/doc4.xml","form_type":"4"}},{"id":2749649,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-04-14T16:43:36.000Z","date":"2021-04-12","kind":"exercise","acquired":true,"shares":5300,"price":0.3,"value":1590.0,"ownership":{"direct":true},"balance_after":76487,"source":{"system":"sec-edgar","filing":"0001209191-21-026666","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919121026666/doc4.xml","form_type":"4"}},{"id":2761633,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-04-02T16:32:36.000Z","date":"2021-04-01","kind":"exercise","acquired":false,"shares":9996,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-quarter (1/4th) of the shares subject to the option vested on July 1, 2017, and one-twelfth (1/12th) of the remaining shares subject to the option vested or shall vest in equal quarterly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":0,"derivative":{"exercise_price":0.11,"expiration_date":"2027-02-05","underlying":"Common Stock","underlying_shares":9996},"source":{"system":"sec-edgar","filing":"0001209191-21-024612","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919121024612/doc4.xml","form_type":"4"}},{"id":2761632,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-04-02T16:32:36.000Z","date":"2021-04-01","kind":"exercise","acquired":true,"shares":9996,"price":0.11,"value":1099.56,"ownership":{"direct":true},"balance_after":71187,"source":{"system":"sec-edgar","filing":"0001209191-21-024612","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919121024612/doc4.xml","form_type":"4"}},{"id":2789373,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-03-15T16:43:04.000Z","date":"2021-03-11","kind":"exercise","acquired":false,"shares":5300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Immediately exercisable."}],"balance_after":140305,"derivative":{"exercise_price":0.3,"expiration_date":"2028-03-25","underlying":"Common Stock","underlying_shares":5300},"source":{"system":"sec-edgar","filing":"0001209191-21-020480","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919121020480/doc4.xml","form_type":"4"}},{"id":2789372,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-03-15T16:43:04.000Z","date":"2021-03-11","kind":"sale","acquired":false,"shares":4,"price":65.47,"value":261.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":61191,"source":{"system":"sec-edgar","filing":"0001209191-21-020480","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919121020480/doc4.xml","form_type":"4"}},{"id":2789371,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-03-15T16:43:04.000Z","date":"2021-03-11","kind":"sale","acquired":false,"shares":3557,"price":64.72,"value":230209.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.325 to $65.295 inclusive."}],"balance_after":61195,"source":{"system":"sec-edgar","filing":"0001209191-21-020480","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919121020480/doc4.xml","form_type":"4"}},{"id":2789370,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-03-15T16:43:04.000Z","date":"2021-03-11","kind":"sale","acquired":false,"shares":1739,"price":63.99,"value":111278.61,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.31 to $64.30 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3)."}],"balance_after":64752,"source":{"system":"sec-edgar","filing":"0001209191-21-020480","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919121020480/doc4.xml","form_type":"4"}},{"id":2789369,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-03-15T16:43:04.000Z","date":"2021-03-11","kind":"exercise","acquired":true,"shares":5300,"price":0.3,"value":1590.0,"ownership":{"direct":true},"balance_after":66491,"source":{"system":"sec-edgar","filing":"0001209191-21-020480","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919121020480/doc4.xml","form_type":"4"}},{"id":2826886,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-03-01T16:54:14.000Z","date":"2021-02-26","kind":"exercise","acquired":false,"shares":33200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-quarter (1/4th) of the shares subject to the option vested on July 1, 2017, and one-twelfth (1/12th) of the remaining shares subject to the option vested or shall vest in equal quarterly installments thereafter, subject to the Reporting Person continuing to provide service through each such date"}],"balance_after":9996,"derivative":{"exercise_price":0.11,"expiration_date":"2027-02-05","underlying":"Common Stock","underlying_shares":33200},"source":{"system":"sec-edgar","filing":"0001209191-21-015278","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919121015278/doc4.xml","form_type":"4"}},{"id":2826885,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-03-01T16:54:14.000Z","date":"2021-02-26","kind":"exercise","acquired":true,"shares":33200,"price":0.11,"value":3652.0,"ownership":{"direct":true},"balance_after":61191,"source":{"system":"sec-edgar","filing":"0001209191-21-015278","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919121015278/doc4.xml","form_type":"4"}},{"id":2859536,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-02-16T17:47:51.000Z","date":"2021-02-11","kind":"exercise","acquired":false,"shares":5300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Immediately exercisable."}],"balance_after":145605,"derivative":{"exercise_price":0.3,"expiration_date":"2028-03-25","underlying":"Common Stock","underlying_shares":5300},"source":{"system":"sec-edgar","filing":"0001209191-21-010880","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919121010880/doc4.xml","form_type":"4"}},{"id":2859535,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-02-16T17:47:51.000Z","date":"2021-02-11","kind":"sale","acquired":false,"shares":14,"price":68.05,"value":952.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":27991,"source":{"system":"sec-edgar","filing":"0001209191-21-010880","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919121010880/doc4.xml","form_type":"4"}},{"id":2859534,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-02-16T17:47:51.000Z","date":"2021-02-11","kind":"sale","acquired":false,"shares":262,"price":67.05,"value":17567.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.69 to $67.635 inclusive."}],"balance_after":28005,"source":{"system":"sec-edgar","filing":"0001209191-21-010880","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919121010880/doc4.xml","form_type":"4"}},{"id":2859533,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-02-16T17:47:51.000Z","date":"2021-02-11","kind":"sale","acquired":false,"shares":1845,"price":65.99,"value":121751.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.355 to $66.24 inclusive."}],"balance_after":28267,"source":{"system":"sec-edgar","filing":"0001209191-21-010880","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919121010880/doc4.xml","form_type":"4"}},{"id":2859532,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-02-16T17:47:51.000Z","date":"2021-02-11","kind":"sale","acquired":false,"shares":1272,"price":64.93,"value":82590.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.345 to $65.34 inclusive."}],"balance_after":30112,"source":{"system":"sec-edgar","filing":"0001209191-21-010880","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919121010880/doc4.xml","form_type":"4"}},{"id":2859531,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-02-16T17:47:51.000Z","date":"2021-02-11","kind":"sale","acquired":false,"shares":1460,"price":63.74,"value":93060.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.345 to $64.34 inclusive."}],"balance_after":31384,"source":{"system":"sec-edgar","filing":"0001209191-21-010880","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919121010880/doc4.xml","form_type":"4"}},{"id":2859530,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-02-16T17:47:51.000Z","date":"2021-02-11","kind":"sale","acquired":false,"shares":447,"price":62.85,"value":28093.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.33 to\n$63.29 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and\nExchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in\nfootnotes (2), (3), (4), (5) and (6)."}],"balance_after":32844,"source":{"system":"sec-edgar","filing":"0001209191-21-010880","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919121010880/doc4.xml","form_type":"4"}},{"id":2859529,"issuer":{"id":6242,"kind":"organization","name":"Keros Therapeutics, Inc."},"owners":[{"id":125305,"kind":"person","name":"Lachey Jennifer","position":1,"cik":"0001808322","reported_name":"Lachey Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-02-16T17:47:51.000Z","date":"2021-02-11","kind":"exercise","acquired":true,"shares":5300,"price":0.3,"value":1590.0,"ownership":{"direct":true},"balance_after":33291,"source":{"system":"sec-edgar","filing":"0001209191-21-010880","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808322/000120919121010880/doc4.xml","form_type":"4"}}],"next_cursor":"2021-02-16T17:47:51.000000Z,2859529"}